Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2012

01.03.2012 | Reviews

Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis

verfasst von: Jennifer M. Gierisch, PhD, MPH, Lori A. Bastian, MD, MPH, Patrick S. Calhoun, PhD, Jennifer R. McDuffie, PhD, John W. Williams Jr., MD, MHSc

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

OBJECTIVES

We conducted a systematic literature review of smoking cessation interventions for patients with histories of depressive disorders or current significant depressive symptoms. We examined the comparative effectiveness of smoking cessation strategies on abstinence rates, differential effects of cessation strategies by depression status (i.e., history positive vs. current depression), and differential effects by gender.

DATA SOURCES

Peer-reviewed literature in MEDLINE, Embase, PsycINFO, and Cochrane Library.

Study eligibility criteria, participants, and interventions

Randomized controlled trials or secondary analysis of RCT data comparing two or more smoking cessation interventions or intervention to control, and reporting cessation outcomes in adults with depression.

STUDY APPRAISAL AND SYNTHESIS METHODS

Two trained researchers screened articles for inclusion. When possible, we estimated pooled risk ratios with 95% confidence intervals by using a random effects model with the Mantel–Haenszel method. We synthesized other studies qualitatively. We classified each intervention as antidepressants, nicotine replacement therapy (NRT), brief smoking cessation counseling, smoking cessation behavioral counseling, or behavioral mood management.

RESULTS

We identified 16 unique RCTs, of which, only three trials recruited participants with current depression. Meta-analysis demonstrated a small, positive effect of adding behavioral mood management (RR = 1.41, 95% CI 1.01–1.96). All included antidepressant trials showed small, positive effects, but risk ratio summary was not significant (RR = 1.31, 95% CI 0.73–2.34). Three NRT trials demonstrated small, positive effects on smoking cessation rates. We found insufficient evidence to examine gender and depression status moderator effects.

LIMITATIONS

Few RCTs exist that test smoking cessation interventions among adults with depression. To make meaningful comparisons, we created broad intervention categories that contained heterogeneity.

CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS

Few trials enrolled smokers with current depression. Most of data identified were from subgroup analyses of patients history-positive for depression. However, several promising interventions exist. Healthcare providers should consider encouraging their patients with significant depressive symptoms or depression histories to seek smoking cessation services that include NRT and behavioral mood management.
Literatur
1.
Zurück zum Zitat Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058.PubMedCrossRef Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058.PubMedCrossRef
2.
Zurück zum Zitat Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–45.PubMedCrossRef Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–45.PubMedCrossRef
3.
Zurück zum Zitat Ziedonis D, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research. 2008;10:1691–715.PubMedCrossRef Ziedonis D, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research. 2008;10:1691–715.PubMedCrossRef
4.
Zurück zum Zitat Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol. 2009;5:409–31.PubMedCrossRef Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol. 2009;5:409–31.PubMedCrossRef
5.
Zurück zum Zitat Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606–10.PubMedCrossRef Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606–10.PubMedCrossRef
6.
Zurück zum Zitat Kenney BA, Holahan CJ, Holahan CK, Brennan PL, Schutte KK, Moos RH. Depressive symptoms, drinking problems, and smoking cessation in older smokers. Addict Behav. 2009;34:548–53.PubMedCrossRef Kenney BA, Holahan CJ, Holahan CK, Brennan PL, Schutte KK, Moos RH. Depressive symptoms, drinking problems, and smoking cessation in older smokers. Addict Behav. 2009;34:548–53.PubMedCrossRef
7.
Zurück zum Zitat Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003;71:292–301.PubMedCrossRef Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003;71:292–301.PubMedCrossRef
8.
Zurück zum Zitat Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357:1929–32.PubMedCrossRef Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357:1929–32.PubMedCrossRef
9.
Zurück zum Zitat Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001;15:13–7.PubMedCrossRef Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001;15:13–7.PubMedCrossRef
10.
Zurück zum Zitat Pomerleau CS, Zucker AN, Stewart AJ. Characterizing concerns about post-cessation weight gain: Results from a national survey of women smokers. Nicotine and Tobacco Research. 2001;3:51–60.PubMedCrossRef Pomerleau CS, Zucker AN, Stewart AJ. Characterizing concerns about post-cessation weight gain: Results from a national survey of women smokers. Nicotine and Tobacco Research. 2001;3:51–60.PubMedCrossRef
11.
Zurück zum Zitat Tsoh JY, Humfleet GL, Munoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. A J Psychiatry. 2000;157:368–74.CrossRef Tsoh JY, Humfleet GL, Munoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. A J Psychiatry. 2000;157:368–74.CrossRef
12.
Zurück zum Zitat Pratt LA, Brody DJ. Depression and smoking in the U.S. household population aged 20 and over, 2005–2008. NCHS Data Brief. 2010:1–8. Pratt LA, Brody DJ. Depression and smoking in the U.S. household population aged 20 and over, 2005–2008. NCHS Data Brief. 2010:1–8.
13.
Zurück zum Zitat Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008.
14.
Zurück zum Zitat Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. SOURCE Cochrane Database Syst Rev. 2007 Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. SOURCE Cochrane Database Syst Rev. 2007
15.
Zurück zum Zitat Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2008.
16.
Zurück zum Zitat Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006.
17.
Zurück zum Zitat Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005.
18.
Zurück zum Zitat Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005.
19.
Zurück zum Zitat Weinberger AH, Maciejewski PK, McKee SA, Reutenauer EL, Mazure CM. Gender differences in associations between lifetime alcohol, depression, panic disorder, and posttraumatic stress disorder and tobacco withdrawal. Am J Addict. 2009;18:140–7.PubMedCrossRef Weinberger AH, Maciejewski PK, McKee SA, Reutenauer EL, Mazure CM. Gender differences in associations between lifetime alcohol, depression, panic disorder, and posttraumatic stress disorder and tobacco withdrawal. Am J Addict. 2009;18:140–7.PubMedCrossRef
20.
Zurück zum Zitat Haas AL, Munoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol. 2004;72:563–70.PubMedCrossRef Haas AL, Munoz RF, Humfleet GL, Reus VI, Hall SM. Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol. 2004;72:563–70.PubMedCrossRef
21.
Zurück zum Zitat Hitsman B, Moss TG, Montoya ID, George TP. Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry. 2009;54:368–78.PubMed Hitsman B, Moss TG, Montoya ID, George TP. Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry. 2009;54:368–78.PubMed
22.
23.
Zurück zum Zitat Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW. Comparative effectiveness of smoking cessation treatments for patients with depression: A systematic review and meta-analysis of the evidence. VA-ESP Project #09-010; 2010 Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW. Comparative effectiveness of smoking cessation treatments for patients with depression: A systematic review and meta-analysis of the evidence. VA-ESP Project #09-010; 2010
25.
Zurück zum Zitat Hall SM, Reus VI, Muñoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatr. 1998;8:683–90.CrossRef Hall SM, Reus VI, Muñoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatr. 1998;8:683–90.CrossRef
26.
Zurück zum Zitat Hall SM, Muñoz RF, Reus VI, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol. 1996;5:1003–9. Hall SM, Muñoz RF, Reus VI, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol. 1996;5:1003–9.
27.
Zurück zum Zitat Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRef Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRef
28.
29.
Zurück zum Zitat Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef
30.
Zurück zum Zitat Higgins JP, Greenberg S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org. Accessed September 27, 2011 Higgins JP, Greenberg S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.​cochrane-handbook.​org. Accessed September 27, 2011
31.
Zurück zum Zitat Munoz RF, Marin BV, Posner SF, Perez-Stable EJ. Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers. Am J Community Psychol. 1997;25:325–43.PubMedCrossRef Munoz RF, Marin BV, Posner SF, Perez-Stable EJ. Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers. Am J Community Psychol. 1997;25:325–43.PubMedCrossRef
32.
Zurück zum Zitat Vickers KS, Patten CA, Lewis BA, et al. Feasibility of an exercise counseling intervention for depressed women smokers. Nicotine & Tobacco Research. 2009;8:985–95.CrossRef Vickers KS, Patten CA, Lewis BA, et al. Feasibility of an exercise counseling intervention for depressed women smokers. Nicotine & Tobacco Research. 2009;8:985–95.CrossRef
33.
Zurück zum Zitat Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Publ Health. 2006;10:1808–14.CrossRef Hall SM, Tsoh JY, Prochaska JJ, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. Am J Publ Health. 2006;10:1808–14.CrossRef
34.
Zurück zum Zitat Evins AE, Culhane MA, Alpert JE, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008;6:660–6.CrossRef Evins AE, Culhane MA, Alpert JE, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008;6:660–6.CrossRef
35.
Zurück zum Zitat Covey LS, Glassman AH, Stetner F, Rivelli S, Stage K. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. The American Journal of Psychiatry. 2002;10:1731–7.CrossRef Covey LS, Glassman AH, Stetner F, Rivelli S, Stage K. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. The American Journal of Psychiatry. 2002;10:1731–7.CrossRef
36.
Zurück zum Zitat Brown RA, Kahler CW, Niaura R, et al. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001;69:471–80.PubMedCrossRef Brown RA, Kahler CW, Niaura R, et al. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001;69:471–80.PubMedCrossRef
37.
Zurück zum Zitat MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 2010;78:55–61.PubMedCrossRef MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 2010;78:55–61.PubMedCrossRef
38.
Zurück zum Zitat Duffy SA, Ronis DL, Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15:2203–8.PubMedCrossRef Duffy SA, Ronis DL, Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15:2203–8.PubMedCrossRef
39.
Zurück zum Zitat Hall SM, Munoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994;62:141–6.PubMedCrossRef Hall SM, Munoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994;62:141–6.PubMedCrossRef
40.
Zurück zum Zitat Hayford KE, Patten CA, Rummans TA, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatr. 1999;174:173–8.CrossRef Hayford KE, Patten CA, Rummans TA, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatr. 1999;174:173–8.CrossRef
41.
Zurück zum Zitat Saules KK, Schuh LM, Arfken CL, Reed K, Kilbey MM, Schuster CR. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy. Am J Addict. 2004;13:438–46.PubMedCrossRef Saules KK, Schuh LM, Arfken CL, Reed K, Kilbey MM, Schuster CR. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy. Am J Addict. 2004;13:438–46.PubMedCrossRef
42.
Zurück zum Zitat Covey LS, Glassman AH, Stetner F. Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis. 1999;1:31–40.CrossRef Covey LS, Glassman AH, Stetner F. Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis. 1999;1:31–40.CrossRef
43.
Zurück zum Zitat Kinnunen T, Doherty K, Militello FS, Garvey AJ. Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. J Consult Clin Psychol. 1996;4:791–8. Kinnunen T, Doherty K, Militello FS, Garvey AJ. Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. J Consult Clin Psychol. 1996;4:791–8.
44.
Zurück zum Zitat Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial. Int J Psychiatr Med. 2008;3:373–89.CrossRef Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial. Int J Psychiatr Med. 2008;3:373–89.CrossRef
45.
Zurück zum Zitat Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction. 2006;101:1814–21.PubMedCrossRef Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction. 2006;101:1814–21.PubMedCrossRef
46.
Zurück zum Zitat Haaga DA, Thorndike FP, Friedman-Wheeler DG, Pearlman MY, Wernicke RA. Cognitive coping skills and depression vulnerability among cigarette smokers. Addict Behav. 2004;29:1109–22.PubMedCrossRef Haaga DA, Thorndike FP, Friedman-Wheeler DG, Pearlman MY, Wernicke RA. Cognitive coping skills and depression vulnerability among cigarette smokers. Addict Behav. 2004;29:1109–22.PubMedCrossRef
47.
Zurück zum Zitat Kahler CW, Brown RA, Ramsey SE, et al. Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. J Abnorm Psychol. 2002;111:670–5.PubMedCrossRef Kahler CW, Brown RA, Ramsey SE, et al. Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. J Abnorm Psychol. 2002;111:670–5.PubMedCrossRef
48.
Zurück zum Zitat Kahler CW, Brown RA, Strong DR, Lloyd-Richardson EE, Niaura R. History of major depressive disorder among smokers in cessation treatment: associations with dysfunctional attitudes and coping. Addict Behav. 2003;28:1033–47.PubMedCrossRef Kahler CW, Brown RA, Strong DR, Lloyd-Richardson EE, Niaura R. History of major depressive disorder among smokers in cessation treatment: associations with dysfunctional attitudes and coping. Addict Behav. 2003;28:1033–47.PubMedCrossRef
49.
Zurück zum Zitat Carmody TP. Affect regulation, nicotine addiction, and smoking cessation. J Psychoactive Drugs. 1992;24:111–22.PubMedCrossRef Carmody TP. Affect regulation, nicotine addiction, and smoking cessation. J Psychoactive Drugs. 1992;24:111–22.PubMedCrossRef
50.
Zurück zum Zitat Hall SM, Munoz RF, Reus VI, Sees KL. Nicotine, negative affect, and depression. J Consult Clin Psychol. 1993;61:761–7.PubMedCrossRef Hall SM, Munoz RF, Reus VI, Sees KL. Nicotine, negative affect, and depression. J Consult Clin Psychol. 1993;61:761–7.PubMedCrossRef
51.
Zurück zum Zitat Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38.PubMedCrossRef Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38.PubMedCrossRef
52.
Zurück zum Zitat Williams JW Jr. Pignone M, Ramirez G, Perez Stellato C. Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry. 2002;24:225–37.PubMedCrossRef Williams JW Jr. Pignone M, Ramirez G, Perez Stellato C. Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry. 2002;24:225–37.PubMedCrossRef
53.
Zurück zum Zitat An LC, Zhu SH, Nelson DB, et al. Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med. 2006;166:536–42.PubMedCrossRef An LC, Zhu SH, Nelson DB, et al. Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med. 2006;166:536–42.PubMedCrossRef
54.
Zurück zum Zitat Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Quick Reference Guide for Clinicians. Rockville, MD: US Department of Health and Human Services. Public Health Service. April 2009. Available at: http://www.ahrq.gov/clinic/tobacco/tobaqrg.pdf. Accessed September 27, 2011. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Quick Reference Guide for Clinicians. Rockville, MD: US Department of Health and Human Services. Public Health Service. April 2009. Available at: http://​www.​ahrq.​gov/​clinic/​tobacco/​tobaqrg.​pdf. Accessed September 27, 2011.
55.
Zurück zum Zitat Gelenberg AJ, De Leon J, Evins AE, Parks JJ, Rigotti NA. Smoking cessation in patients with psychiatric disorders. Primary Care Companion to the Journal of Clinical Psychiatry. 2008;10:52–8.PubMedCrossRef Gelenberg AJ, De Leon J, Evins AE, Parks JJ, Rigotti NA. Smoking cessation in patients with psychiatric disorders. Primary Care Companion to the Journal of Clinical Psychiatry. 2008;10:52–8.PubMedCrossRef
Metadaten
Titel
Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis
verfasst von
Jennifer M. Gierisch, PhD, MPH
Lori A. Bastian, MD, MPH
Patrick S. Calhoun, PhD
Jennifer R. McDuffie, PhD
John W. Williams Jr., MD, MHSc
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2012
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1915-2

Weitere Artikel der Ausgabe 3/2012

Journal of General Internal Medicine 3/2012 Zur Ausgabe

Clinical Practice: Clinical Images

Overcoming the Rigors of Klebsiella pneumoniae

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.